French sales subsidiary of Japanese pharma firm Eisai divests rights of neurology drugs for € 56.5 M

Japan headquartered pharma company Eisai Co. has announced that its French sales subsidiary Eisai S.A.S. has entered int...

April 9, 2024 | Tuesday | News
Japan's NS Pharma & UK-based MiNA Therapeutics lay focus on rare diseases of Central Nervous System

NS Pharma, Inc. has announced that its parent company, Nippon Shinyaku Co., headquartered in Kyoto, Japan, has ente...

April 4, 2024 | Thursday | News
Polyplus Launches Innovative Plasmid for AAV Vector Production, Strengthening Its Position in Biologic and Cell & Gene Therapy Solutions

  Polyplus (part of Sartorius, a distinguished upstream solutions provider for biologic and cell and gene the...

March 27, 2024 | Wednesday | News
Korean startup Lunit delivers AI-powered cancer screening solution to France and Portugal

Lunit, a leading provider of artificial intelligence (AI)-powered solutions for cancer diagnostics and therapeutics, has...

March 18, 2024 | Monday | News
TFS HealthScience establishes operation in Australia expanding its CRO capabilities to APAC

TFS HealthScience (TFS), a leading global Contract Research Organization (CRO), has expanded into the Asia Pacific&...

March 12, 2024 | Tuesday | News
New ‘spin freezing’ technique to enhance future mRNA vaccines

A top-ranking public research university in Belgium has received funding from Norway-based Coalition for Epidemic Prepar...

March 12, 2024 | Tuesday | News
Polyplus expands GMP offer with protein production and adds GMP capacity in Belgium

Polyplus (part of Satorius) company, Xpress Biologics, has received a good manufacturing practice (GMP) c...

March 6, 2024 | Wednesday | News
First ever large-scale GMP manufacturing of therapeutic IgE antibody achieved in the UK

Epsilogen, a leading immunoglobulin E (IgE) antibodies developer treating cancer, and global biopharma leader Lonza have...

March 5, 2024 | Tuesday | News
Medigene AG expands patent portfolio in Japan for iM-TCR Technology

Medigene AG, an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapie...

March 4, 2024 | Monday | News
Japan's Daiichi Sankyo invests €1B in Germany site, expanding into innovation centre

With investments of approximately one billion euros, Japan headquartered Daiichi Sankyo will expand its production and ...

February 29, 2024 | Thursday | News
Eppendorf Innovation Company strengthens access to US startup scene

The Eppendorf Innovation Company (EpIC) – a  division of Eppendorf SE – continues to expand its interna...

February 14, 2024 | Wednesday | News
Takeda, Dundee and Cambridge reunite in fight against dementia

UK-based University of Dundee’s Drug Discovery Unit has announced a renewed partnership with Japanese pharmaceut...

February 14, 2024 | Wednesday | News
SGD Pharma Launches Type I Vials with Corning's Velocity® Coating

SGD Pharma, global market leader in molded glass primary packaging solutions for the pharmaceutical industry, announces ...

February 5, 2024 | Monday | News
SGD Pharma expands capacity of siliconised glass vials for pharma packaging in France

SGD Pharma has announced the opening of a new siliconisation operation at its state-of-the-art Saint-Quentin Lamott...

January 23, 2024 | Tuesday | News
VirtualiSurg Mediverse accelerates training for surgery and health-tech sectors globally

Paris-headquartered international medtech firm, VirtualiSurg has created an immersive mediverse – a virtual learni...

January 17, 2024 | Wednesday | News
Merck expands colorectal cancer portfolio through licensing agreement with Inspirna for $45 M

Merck, a leading science and technology company, has announced a licensing agreement with US-based firm Inspirna, Inc. f...

January 5, 2024 | Friday | News
Roche buys LumiraDx’s Point-of-Care technology for more than $300 M

Swiss firm Roche has announced the entry into a definitive agreement to acquire select parts of the UK-based LumiraDx gr...

December 31, 2023 | Sunday | News
Novo Nordisk Foundation commits up to $260 M to establish research and vaccine development initiative

Denmark-based Novo Nordisk Foundation is committing up to DKK 1.8 billion ($260 million) to establish a state-...

December 18, 2023 | Monday | News